The question whether or not target cell N-linked carbohydrate participates in cytotoxic T lymphocyte (CTL) mediated cytolysis has been in contention for well over a decade. Much of the evidence supporting a role for N-linked carbohydrate stems from the treatment of target cells with the glycosylation inhibitor tunicamycin (TM). In this report, we show that treatment of targets with TM, but not other inhibitors of complex carbohydrate formation (swainsonine, 1-deoxynojirimycin, and 1-deoxymannojirimycin), abrogates the lytic response. We conclude that N-linked complex carbohydrates are not absolutely required for the maturation or function of any target cell glycoconjugate directly involved in the lytic process. However, we show that TM treatment of target cells leads to the loss of an MHC class la epitope known to be required for T cell triggering. Further, we show that only target cells expressing class la molecules with functional glycosylation sequons are subject to the TM effect. From these results we conclude that while N-linked glycosylation of native MHC class la molecules is required for antigen presentation, the exact structural motif of the glycan is not important.
Introduction
Cytotoxic lymphocytes and target cell glycoconjugate structure Allogeneic cytotoxic T lymphocytes (CTL) recognize and subsequently kill target cells bearing specific non-self major histocompatibility complex (MHC) antigens on their surface. CTL responses to MHC class I recognition by the CTL TCR/ CD8 complex are enhanced by target cell accessory molecules, such as B7, ICAM-1, and LFA-3, which may occur on the target cell surface and which participate in CTL adhesion and/ or costimulatory signaling (for a recent review, see Berke, 1994) . Experimental systems utilizing cultured CTL lines and clones to recognize and lyse cultured target cells in vitro have been remarkably successful in dissecting many of the molecular mechanisms involved in the processes of recognition, adhesion, triggering, and delivery of the lethal hit, and several such reports have implicated target cell surface glycoconjugate structure as being important for CTL recognition.
Much of the data supporting a role for target cell N-linked carbohydrate structure originates from the use of a single glycosylation inhibitor, tunicamycin (TM), which blocks the first step in the biosynthetic pathway for the formation of the dolichol pyrophosphoryl oligosaccharide precursor to the N-linked core structure. TM treatment usually results in the accumulation of membrane proteins devoid of N-linked carbohydrate of any kind. Frequently, however, there also is a diminution in the quantity of the protein expressed on the cell surface and, in some cases, inhibition of glycosylation can lead to defects in protein maturation and transport (Elbein, 1993) . Such phenomena can make interpretation of data gathered using glycosylation inhibitors difficult. Nonetheless, TM continues to be used in attempts to define roles for the glycan moities of various cell surface glycoconjugates as evidenced by the occurrence of over 150 references to TM in a Medline search of the molecular cell biology literature for 1994-95. Hart (1982) reported that pretreatment of stimulator cells with tunicamycin abrogated the ability of such cells to activate allogeneic thymocytes in a mixed lymphocyte reaction. That same year Black et al. (1981) reported that TM pretreatment of P815 cells significantly blocks the ability of such cells to present vesicular stomatitus virus (VSV) antigen to VSV sensitized syngeneic CTL but suggested that the response of allogeneic CTL is variable and depends to some extent on the H-2 background of the effector cells. Later, Pimlott and Miller (1986) demonstrated that TM pretreatment of P815 tumor cells reduces their capacity to serve as targets in a 5l Cr-release assay, and as competitors in a cold target inhibition assay when challenged with alloreactive CTL. These reports were able to exclude loss of MHC class I antigens from the cell surface as a likely cause of the observed inhibition and suggested that the TM effect was due to the loss of N-linked carbohydrate from cell surface glycoconjugates.
The tunicamycin effect

Glycosylation of MHC class la and class la function
Several reports have suggested that glycosylation of murine MHC class la molecules plays no significant role in antigen recognition by either allo-or syngeneic CTL. Goldstein and Mescher (1985) have shown that purified, deglycosylated K k inserted into liposomes is competent to sponsor development of allospecific CTL in spleen cell cultures initiated from previously primed mice. Further, Ozato and coworkers (Miyezake et al, 1986) have shown that L d mutated in vitro to be devoid of N-linked glycosylation sequons can be recognized by alloreactive CTL clones raised against native antigen and can effectively present foreign (VSV) antigen to MHC class la restricted syngeneic CTL. Nonetheless, recent work by Shen and Kane (1995) has demonstrated the existence of two distinct subsets of K b molecules which differ in their ability to stimulate alloreactive CTL. The major difference between the two subsets is in their degree of glycosylation, the nonstimulatory set being more highly glycosylated.
Given this background, it seemed to us that the role of Nlinked complex carbohydrates in alloreactive CTL recognition and lysis of class la bearing targets was still in question, as was the mechanism of TM action on class la alloantigens, and that further examination of the effects of treating target cells with inhibitors of glycosylation might yet enable a resolution to these questions.
Results
The effect of tunicamycin treatment on target cell lysis by alloreactive CTL As shown by others (Keren and Berke, 1984; Pimlott and Miller, 1986) , TM treated target cells are refractory to lysis by allogeneic CTL. While previous reports have used 5 day mixed lymphocyte cultures as a source of alloreactive CTL and the level of inhibition of lysis following TM treatment has been modest, here we show that TM treatment of target cells causes a profound and uniform inhibition of lysis mediated by a(3TCR + , CD8 + CTL clones. Further, after examining several individual clones from two different mixed lymphocyte cultures, we found no class la specific clones able to efficiently lyse TM treated P815 targets (Figure 1) .
Despite a report to the contrary (Black et ai, 1981) 
DNM, DMM, and swainsonine treatment of target cells
Three other inhibitors of N-linked glycosylation were also used for treatment of target cells and their effect on allogeneic CTL sponsored lysis was assessed. Deoxynojirimycin (a glucosidase I and II inhibitor), deoxymannojirimycin (a mannosidase I inhibitor), and swainsonine (a mannosidase II inhibitor) were optimized for use on both P815 and EL-4 cells (Figure 2 ). All three inhibitors were as effective as TM in altering cell-surface complex carbohydrate structure as assayed by PHA-L binding. Further, treatment of cells with these inhibitors led to an increase in high mannose structures as indicated by the increased Con-A binding, as would be expected following inhibition of the above mentioned enzymes.
To ensure that the inhibitor treatments were affecting appropriate structures on the target cell surface, L d molecules were immunopurified from cell populations treated with swainsonine and DMM. The N-linked carbohydrate structures were then tested for sensitivity to digestion with the endoglycosidase, Endo-H. As seen in Figure 3 The peak channel number from each flow cytogram in A was used to calculate the peak channel ratio (peak channel number of expenmental sample divided by the peak channel number for the control). The peak channel ratio was then plotted versus inhibitor concentration. (C) The process used to generate A and B was repeated using the inhibitors DMM, DNM, and swainsonine. The resultant cells were analysed by staining with the Hit-conjugated lectins PHA-L and Con A.
cells treated with either swainsonine or DMM is sensitive to digestion by Endo-H indicating that it is composed of high mannose or hybrid-type carbohydrate structures. Carbohydrate on L d molecules from control cells is resistant. Further, L d molecules from DMM treated cells is clearly of lower molecular weight than L d from control cells, and the molecular weight is reduced to that of an unglycosylated molecule upon enzyme treatment. These results, combined with the data from Figure 2 , support the contention that these inhibitors are indeed modifying the cell surface carbohydrate structure in the expected ways.
Treatment of target cells with these inhibitors, however, exerts no substantive effect on the ability of allogeneic CTL to recognize and lyse the target. Both P815 and EL-4 ( Figure 4 ) remained almost as sensitive to lysis as the untreated control cells. From these results we conclude that complex-type carbohydrate structures are not required on either MHC I or any ancillary target cell molecules mediating CTL recognition.
The tunicamycin effect
The results reported above are consistent with the idea that it is only the process of target cell N-linked glycosylation itself that is somehow required for CTL recognition of target cells, and that it is interference with this process and not the alteration of cell surface carbohydrate structure that leads to target cell dysfunction. However, these results do not address the issue of whether the TM effect is mediated through inhibition of protein glycosylation leading to the loss or conformational alteration of some required cell surface molecule, or whether the effect is mediated through some as yet undefined internal mechanism. Therefore, we felt it was important to show that TM treatment was not ablating the ability of target cells to respond to lytic signals. TM treated targets were challenged in a redirected assay (Mosley et ai, 1990) , in which the CTL were preincubated with the activating anti-CD3 monoclonal antibody R3/ 7/159 prior to addition to the targets. As shown in TM-treated P815 cells are completely responsive to lysis by the anti-CD3 treated CTL.
It is known that the only MHC class I and, to a lessor extent, ICAM-1 are required for target recognition and lysis by CD8 + , TCR a,P + alloreactive CTL (Martz, 1993) . Treatment with TM does not affect the level of ICAM-1 expression on the target cell surface (Mehta et al., 1994; E.U. Bagriacik, unpublished observations) . This suggested that the major TM-induced defect might lay exclusively within the MHC la molecule itself. To address this issue, we exploited the existence of structure specific monoclonal antibodies to D d . Treatment of P815 with TM leads to some loss of MHC la molecules from the cell surface, however, not in sufficient amounts to account for the total ablation of lysis. As seen in Figure 6A , the binding of both mAb 34-5-8S which is sensitive to the presence of both polypeptide and P 2 -m (Otten et al, 1992) and the relatively conformation insensitive mAb 34-2-12S are identically and only moderately reduced following TM treatment. These results are consistent with previous reports using polyclonal antibodies (Pimlot and Miller, 1986) A possible solution to this conundrum is suggested by our observation that the binding of a third monoclonal (Ml/42) is completely eliminated by TM treatment of both P815 cells and EL-4 cells ( Figure 6B,C) . While Ml/42 binding is known to be dependent on the presence of f$ 2 -m (Bernabeu et al, 1984) , the binding of 34-5-8S is also dependent on P 2 -m (Otten et al, 1992) . Thus, loss of Ml/42 binding is not likely to be due to disruption of (3 2 -m association. We hypothesize that the loss of the Ml/42 epitope is the result of a conformation^ change induced by TM mediated inhibition of MHC I glycosylation. In experiments using DMM, DNM, and swainsonine, some loss of MHC I was also noted; however, in these cases the level of Ml/42 binding was similar to the binding of the other monoclonals (data not shown).
The direct correlation between the loss of Ml/42 binding and the loss of CTL reactivity seen in this study, and the similar result found in the study of Shen and Kane (1995) , implies that Ml/42 may identify an epitope required for target cell recognition by allogeneic CTL, and that both the process of glycosylation and the structure of the resultant carbohydrate directly influence the occurrence and/or accessibility of this epitope.
The correlation noted above suggests a model for the TM effect in which the blockade of glycosylation by TM results in the appearance on the cell surface of MHC class la molecules having an altered conformation which, albeit still binding peptide and P 2 " m . is n0 longer recognizable by allogeneic CTL. Further, this model makes the prediction that cells expressing an MHC class la molecules devoid of N-linked glycosylation sequons should be resistant to the TM effect.
To test this hypothesis we exploited the existence of two mouse L cell lines (H-2 the CM3-1 line is completely resistant to the TM effect. We conclude that the presence in L d of sequons which activate N-linked glycosylation of the molecule is both necessary and sufficient to induce the TM effect. In the absence of such sequons, TM treatment has no appreciable effect on target cell lysis by alloreactive CTL. set kills control but not TM treated Daudi cells, whereas the other lyses both TM treated and untreated targets. Further, the former is inhibited by plasma membrane oligosaccharides purified from Daudi cells, while the latter is not. To date, however, no MHC class la reactive CTL clone which can recognize and lyse a TM treated target has been identified ( Figure 1 ). In this study we have used several inhibitors of complex oligosaccharide formation to assess the role of glycoconjugate structure in CTL/target cell interaction. Our experiments demonstrate that complex carbohydrates can be profoundly suppressed on the target cell surface without significant effect. Our data supports the contention, originally proposed by others (Goldstein and Mescher, 1985; Miyezaki et al., 1986) , that carbohydrate on MHC class la molecules plays no significant role in CTL recognition of target cells. Further, N-linked complex carbohydrates on target accessory molecules, such as ICAM-1, are not required either. Such a conclusion must be inferred from the lack of any significant quantitative effect on lysis resulting from target cell treatment with either DMM, DNM or SW (Figure 4) .
Discussion
On the other hand, we have confirmed that TM treatment of targets renders them refractory to lysis by alloreactive class la-restricted CTL. It seems unlikely, however, that the ablation of sensitivity is due to loss of functional glycans from the cell surface. First, the cell surface carbohydrate structure can be substantively modified without appreciable loss of function (Figures 3, 4) (Figure 7 ). This observation also supports our contention that the only effect of TM is on the MHC class la molecules themselves.
Binding of the Ml/42 mAb is known to be sensitive to the glycosylation state of the MHC molecule (Shen and Kane, 1995) . Kane's laboratory has shown that Ml/42 distinguishes between K b subsets which only differ with respect to the level of glycosylation, the poorly reactive subset being of higher molecular weight. Interestingly, the poorly reactive subset is also unable to stimulate serine esterase release from alloreactive CTL clones. We hypothesize that the Ml/42 epitope on K , is required for the productive interaction of MHC class la molecules with the CD8/TCR complex on CTL. Further, we suggest that this epitope is, in part, influenced by the process of N-glycosylation, as well as by the glycosylation state of the MHC la molecule, and that alteration of this epitope may be the functional basis for the loss of target cell/CTL interaction following TM treatment.
Because the Ml/42 epitope does not exist on L d , it is not possible to determine directly whether or not such an epitope is lost following TM treatment; however, our model for the TM effect predicts that TM treatment should cause cells expressing native L d to become resistant to lysis by alloreactive CTL, whereas cells expressing L d carrying amino acid changes at all three glycosylation sites should remain sensitive. Our experiments with the Ozato cell lines confirmed this prediction.
The observations presented above raise interesting questions concerning role of glycosylation in determining, at least in part, the final conformation of the MHC class la molecule. It has been suggested that the molecular chaperone calnexin binds glycosylated molecules and senses the folding state of the protein based on the number of terminal glucose residues (Ware et al., 1995) . Inhibition of glycosylation by TM is known to abolish interaction with calnexin. However, calnexin is an unlikely candidate for the TM effect because inhibition of glucose trimming by glycosidase I inhibitors such as DMN and castanospermine is known to abolish interaction with calnexin (Hammond etal, 1994 , Zhang etai, 1995 . If failure to interact with calnexin or other carbohydrate binding chaperones were the primary cause of the TM effect, then DNM treatment should exhibit such an effect as well, yet it does not (Figure 3) . Further, class I molecules lacking glycosylation sequons are retained in the endoplasmic reticulum of TAP deficient cells (Alexander et al., 1990) , suggesting that carbohydrate per se is not required retention of peptide deficient MHC molecules.
It is known that oligosaccharyltransferase is intimately associated with the peptide synthesis and transfer machinery of the ER (Kumar et al., 1995) . Indeed, two of the three subunits of this enzyme are ribophorins, and bind the large ribosomal subunit on the cytoplasmic face of the ER, while the third, enzymatic subunit faces the lumen of the ER. While we have no direct evidence to support this contention, it seems plausible that TM induced shortage of the dolichol-linked oligosaccharide substrate might cause oligosaccharyltransferase to fail to release glycosylation sequons in a timely or appropriate manner. In the case of the MHC I/B 2 m/peptide complex, which must follow a rigorous assembly and folding pathway, such disruptions combined with failure to bind the appropriate chaperones might induce conformational distortions in the final protein complex which result in loss of the Ml/42 epitope and resistance to CTL induced lysis.
Regardless of the exact mechanism involved, in this study we have provided evidence, for the first time, that inhibition of the glycosylation process can have important functional consequences for molecules possessing active N-glycosylation sequons that may not appear in in vitro mutagenesis studies. Further, our studies explicate much of the contradictory literature with respect to the role of glycosylation in defining target cell susceptibility to allogeneic CTL.
Materials and methods
Cell culture
P8I5 cells (TIB 64) and EL-4 cells (TIB 39) were purchased from the American Type Culture Collection and were maintained by regular passage in RPMI-1640 containing 10% fetal calf serum (FBS) and anubiotics. Mouse L cell lines L-L d and CM3-1 (Miyezaki et al., 1986) were the generous gift of Dr. Ted Hansen, Washington University, St. Louis, MO. These lines were maintained in DME with 10% FBS. Allogeneic CTL were generated in BALB/c or C57BL/6 mice according to the protocol of Bloom (1993) , and were maintained in MLC media (RPM1-1640 supplemented with 5 mM HEPES, 2 mM L-glutamme, 50 u,M 2-mercaptoethanol, 6% rat Con A supernatant as an JL-2 source, 10% heat inactivated FBS, and antibiotics). CTL were restimulated regularly using the appropnate allogeneic spleen cells. All cell culture reagents were from Sigma Chemical Co., St. Louis, MO.
Glycosylation inhibitors and treatments
P815 and EL-4. All inhibitors were purchased from Sigma Chemical Co. and maintained as stock solutions at -20°C. Tunicamycin (TM) was prepared in 0.025 M NaOH at a concentration of 2 mg/ml. Swainsonine (SW) was dissolved in 100% ethanol at a concentration of 1 mg/ml. 1-Deoxynojirimycin hydrochloride (DNM) and 1-deoxymannojirimycin hydrochloride (DMM) were dissolved separately in sterile distilled water at a concentration of 100 mM. For treatment, target cells (2.5 x 10 E.U.Bagriacik, A.Kirkpatrick and K^.MIIIer Mouse L cells. For TM treatment of mouse L cells, a modification of the procedure of Swaminathan and Gooding (1983) was used. Briefly, the cells were removed from the substratum by treatment with trypsin-EDTA. The cells were denuded of MHC class la by incubation with papain (10 mg/ml in PBS) for 1 h followed by a 4 h recovery period in complete medium in the presence or absence of 1 jig/ml tunicamycin. The 1 h papain treatment was sufficient to completely inhibit lysis by alloreactive CTL. The 4 h recovery period was sufficient to regain full sensitivity to lysis, (data not shown).
Cytotoxicity assay
Cytotoxicity was determined using a 4 h "Cr-release assay essentially as described by Martz (1993) . Briefly, P814 or ELA target cells (2 x Iff/ml) were labeled with 300 |xCi of "Cr by incubation for 1 h at 37°C. For labeling of mouse L cells, "Cr was added (40 u.Ci/ml) during the 4 h recovery period described above. The cells were washed extensively then mixed (2 x \<T) with varying numbers of effectors in 0.2 ml of MIX in round bottom microtitre plates. After 4 h at 37°C, "Cr in the supernatant was determined by counting 0.1 ml in an ICN Micromedic Systems gamma counter. Percent Specific Lysis (PSL) was calculated according to the formula: PSL = [(£ -S)/(D -S)]100, where E is effector sponsored release, 5 is spontaneous release, and D is detergent sponsored release. Spontaneous release was always less than 25% of the detergent release. Redirected assays (Mosley et ai, 1990) were conducted as described above except that the effector cell population (2 x 10 6 cells) was first incubated with 100 \x\ of culture supernatant containing the anti-mouse CD3 monoclonal antibody (mAb) R3A7/159 (the generous gift of R.L. Mosley and J.Klein, unpublished) or culture supernatant containing an isotype matched control mAb. After incubation on ice for 30 min, the cells were washed and used immediately.
Flow cytometry
The effect of inhibitor treatments on target cell glycoconjugate structure was assessed as described by Voshol et al (1993) using FITC-conjugated lectins (Vector Laboratories, Inc., Burlingame, CA) from Phaseolus vulgaris (PHA-L) and Canavalia ensiformis (Con A). PHA-L binds tri-and tetra-antennary complex carbohydrates (Dennis et al., 1987) while Con A binds branched high mannose type structures (Goldstein and Hayes, 1978) . Treated and untreated cells (4 x 10 3 /ml) were stained with FITC-conjugated lectins (5 (j-g/ml) and analyzed in an EPICS 751 flow cytometer with MDADS II computer (Coulter Electronics, Hialeah, FL).
The effect of inhibitor treatments on target MHC class la expression was assessed using mAb and flow cytometry. Monoclonals used in this study were: 34-5-8S (ATCC-HB 102), 34-2-12S (ATCC-HB 87), 28-14-8S (ATCC-HB27), and Ml/42 (Boehringer Mannheim, Indianapolis, IN). The mAb were used as previously titrated cell culture supematants (34-5-8S, 34-2-12S, and 28-14-8S) or as a purified, FITC-conjugated mAb (M1/42). Except for M1/42, primary mAb binding was visualized by the binding of a FTTC-conjugated, isotype-specific secondary mAb. Negative binding controls were either FTTCconjugated secondary alone (for 34-5-8S, 34-2-12S, and 28-14-8S) or FITCconjugated, isotype-matched irrelevant mAb (for Ml/42).
Immunopurification of L d
P815 cell surface proteins were labeled using ImmunoPure LC-NHS-biotin (Pierce Chemical, Rockford, IL) by the procedure of Lantzand Holmes (1995). Briefly, 10 s cells/ml were labeled by incubation for 30 min at room temperature in 1 mM sulfo-LC-NHS-biotin/PBS. The cells were then washed in PBS and resuspended in lysis buffer (10 mM Tris-HCl, 150 mM NaCl, 0.5% BSA, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 (ig/ml leupeptin and 10 jjig/ml aprotinin, and 0.6% 3-([3-cholamindopropyl]dimethylammonio)-lpropanesulfonate detergent, pH 7.4). Nuclei and cell debris were removed by centrifugation at 11,600 x g for 10 min at 4°C and the lysates were precleared by incubation with 10 7 sheep anti-mouse IgG coated Dynabeads (Dyal, Great Neck, NY) according to the procedure of Worlock et al. (1991) The lysate was subsequently incubated with 10 7 coated Dynabeads which had been incubated in culture supernatant containing the mAb 28-14-8S (ATCC HB-27). This monoclonal is specific for L d . After incubation the beads were washed in lysate buffer containing 400 mM NaCl and the bound protein eluted with 0.5 M acetic acid. After precipitation from 7 volumes of acetone at -20°C, the pellet was dried and resuspended in 50 mM ammonium acetate, 0.075% SDS, pH 6.0, and digested overnight at 37°C with 5 mil of Endo-H (Sigma Chemical Co., St Louis, MO). The sample was then lyophilized and resuspended in sample buffer and separated by electrophoreses in 10% SDS mini-gel (Laemmli, 1970) . The gel was electroblotted onto a PVDF membrane and biotinylated L d proteins were visualized with the Westem-Light Plus Chemiluminescent Detection System (Tropix, Inc., Bedford, MA).
